Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-25
2006-04-25
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S204000, C544S206000, C544S208000, C544S209000
Reexamination Certificate
active
07034021
ABSTRACT:
The invention concerns compounds of general formula (I) wherein: R1, R2, R3, R4, R5 and R6 are as defined in Claim 1. Said compounds are useful in the treatment of pathologies related to the insulin-resistance syndrome.
REFERENCES:
patent: 3287366 (1966-11-01), Newman et al.
patent: 48 064088 (1973-09-01), None
patent: 54 014986 (1979-02-01), None
patent: 99 31088 (1999-06-01), None
“Journal of Medicinal Chemistry, US, American Chemical Society, Washington,” vol. 6, No. 4, pp. 370-378, 1963.
Stevens et al., “Introduction of a triflate group into sterically hindered positions in 1-aryl-4,6-diamino-1,3,5-triazines and their Dimroth rearrangement products,” Journal of Heterocyclic Chemistry, vol. 30, No. 4, pp. 849-853, 1993.
Cravo Daniel
Doare Liliane
Kergoat Micheline
Mesangeau Didier
Moinet Gerard
Balasubramanian Venkataraman
LIPHA
Young & Thompson
LandOfFree
Dihydro-1,3,5-triazine amine derivatives and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydro-1,3,5-triazine amine derivatives and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydro-1,3,5-triazine amine derivatives and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3597087